Hélène Negre, T2EVOLVE Project Leader, and Michael Hudecek, T2EVOLVE Project Coordinator, are speakers at the Onco Cell Therapy Summit Europe in Amsterdam on Thursday, November 3.

Hélène will present the T2EVOLVE Consortium while Michael speaks about new targets and technologies for CAR T cells.

The summit brings together academics, service providers, biotechnology and pharmaceutical companies, and covers the whole range of autologous and allogeneic cell therapy advancements.

More information about the summit is available on their website: 



Share This